Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

65 results about "Ventricular volume" patented technology

The ventricular system in the brain is composed of CSF-filled ventricles and their connecting foraminae. CSF is produced by ependymal cells which line the ventricles. They are continuous with the central canal. Ventricles contain around 1/5 of normal adult CSF volume, which is around 20-25 ml.

Closed loop impedance-based cardiac resynchronization therapy systems, devices, and methods

This document discusses, among other things, systems, devices, and methods measure an impedance and, in response, adjust an atrioventricular (AV) delay or other cardiac resynchronization therapy (CRT) parameter that synchronizes left and right ventricular contractions. A first example uses parameterizes a first ventricular volume against a second ventricular volume during a cardiac cycle, using a loop area to create a synchronization fraction (SF). The CRT parameter is adjusted in closed-loop fashion to increase the SF. A second example measures a septal-freewall phase difference (PD), and adjusts a CRT parameter to decrease the PD. A third example measures a peak-to-peak volume or maximum rate of change in ventricular volume, and adjusts a CRT parameter to increase the peak-to-peak volume or maximum rate of change in the ventricular volume.
Owner:CARDIAC PACEMAKERS INC

IMPLANTABLE MEDICAL DEVICE AND A METHOD COMPRISING MEANS FOR DETECTING AND CLASSIFYING VENTRICULAR TACHYARRHYTMIAS (As Amended)

In a method and implantable medical device for ventricular tachyarrhythmia detection and classification, upon detection of a ventricular tachyarrhythmia based on an electrocardiogram signal, cardiogenic impedance data representative of ventricular volume dynamics are collected and used for classifying the detected tachyarrhythmia as stable or unstable. In the latter case but typically not in the former case, defibrillation shocks or other forms of therapy are applied to combat the unstable ventricular tachyarrhythmia.
Owner:ST JUDE MEDICAL

Cardiac impulse assist system

The invention discloses a cardiac impulse assist system, which comprises a ventricular volume regulating device, a synchronizer and a control device, wherein the ventricular volume regulating device is used for regulating ventricular volumes; a sensor of the synchronizer is connected to the heart; the synchronizer is used for collecting ventricular systole signals; and the control device is used for receiving the ventricular systole signals collected by the synchronizer, and is used for controlling the ventricular volume regulating device to synchronously reduce the ventricular volumes when ventricular systole is performed. An automatic defibrillating device and a synchronous treatment device are arranged in the synchronizer; a defibrillating electrode of the automatic defibrillating device is connected to the heart; a pacing electrode of the synchronous treatment device is implanted into a chamber of the heart. As the ventricular volume regulating device is small in size, the cardiac impulse assist system disclosed by the invention can be implanted into the chamber of the heart. The cardiac impulse assist system disclosed by the invention can be used for completely imitating a ventricular pressure-volume change rule, can work synchronously with cardiac impulse, and can be used for assist the heart to pulsate and do work so as to treat cardiac failure, promote ventricular restoration and repair the perforation of ventricular septum.
Owner:杨碧波

Ventricular volume reduction device and delivery system thereof

The application discloses a ventricular volume reduction device that can be expanded or stretched into a strip shape. The ventricular volume reduction device includes a first bracket and a second bracket with the axes coinciding with each other. The first bracket includes a closed first connecting end and an expanded first edge. The first bracket is gradually expanded along a direction from the first connecting end to the first edge. The second bracket includes a closed second connecting end and an expanded second edge. The second bracket is gradually expanded along a direction from the secondconnecting end to the second edge. The first edge is connected with the second edge, and the first bracket is rotatable around the connecting part of the first edge and the second edge. The first connecting end is provided with a first connecting member, and the second connecting end is provided with a second connecting member. The first connecting member and the second connecting member are respectively used for connecting a delivery system. At least one surface of the first bracket and the second bracket is covered with a flow blocking membrane. The application further provides a delivery system that achieves accurate operation and recycling.
Owner:APT MEDICAL HUNAN INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products